NOVATO, Calif.--(BUSINESS WIRE)--Oct 24, 2025--

QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that it has implemented a 3:1 reverse stock split of the Company’s issued and outstanding common stock which became market effective on October 24, 2025. The market effectiveness has been referenced to by FINRA in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 23, 2025, which Form 8-K referred to market effectiveness on October 24, 2025.

In addition, the Company’s public warrants are being adjusted such that each warrant shall be exercisable for 0.33333809 shares of the Co

See Full Page